ArticleFrontiers in pharmacology2022

Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors.

Yue Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.